BioSpace News Archive

Deals

Takeda Family Member Speaks out Against Takeda Pharma-Shire Deal

The opposition to Takeda Pharmaceutical acquiring Shire has taken on another dimension with a prominent member of the family that created the Japanese pharmaceutical company speaking publicly against the deal.

September 10, 2018
·
2 min read
·
Mark Terry
Policy

Noted Cancer Researcher Fails To Disclose Financial Ties to Pharma Companies in Published Articles

José Baselga, chief medical officer at Memorial Sloan Kettering Cancer Center came under fire this weekend for his failure to disclose financial ties to various pharmaceutical companies when he published research papers in peer-reviewed journals.

September 10, 2018
·
2 min read
·
Alex Keown
Drug Development

After FDA Discussions, Amicus Therapeutics to Push Pompe Disease Program into Phase II

Amicus Therapeutics, headquartered in Cranbury, New Jersey, held a Type C meeting with the U.S. Food and Drug Administration (FDA) regarding its regulatory path for AT-GAA for Pompe Disease. The company released its plans for the drug.

September 10, 2018
·
2 min read
·
Mark Terry
Career Advice

BioSpace’s Top Career Advice: Summer 2018

As the weather cools down, let’s look back at this summer’s most popular career advice on BioSpace.

September 10, 2018
·
2 min read
·
Erin Quinlin
Drug Development

EpicGenetics and Massachusetts General Hospital to Launch Fibromyalgia Clinical Trial

EpicGenetics and Massachusetts General Hospital (MGH) are launching a Phase II clinical trial to test a tuberculosis vaccine, BCG, as a potential treatment for fibromyalgia.

September 10, 2018
·
4 min read
·
Mark Terry